Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 195

1.

[Osteoporosis and arterial stiffness: study of 103 women with mild to moderate risk of cardiovascular disease].

Ageev FT, Barinova IV, Seredenina EM, Orlova IaA, Kuz'mina AE, Masenko VP, Kochetov AG.

Kardiologiia. 2013;53(6):51-8. Russian.

PMID:
23953046
2.

The levels of bone turnover markers in Chinese postmenopausal women: Peking Vertebral Fracture study.

Zhao J, Xia W, Nie M, Zheng X, Wang Q, Wang X, Wang W, Ning Z, Huang W, Jiang Y, Li M, Wang O, Xing X, Sun Y, Luo L, He S, Yu W, Lin Q, Pei Y, Zhang F, Han Y, Tong Y, Che Y, Shen R, Hu Y, Zhou X, Xu L.

Menopause. 2011 Nov;18(11):1237-43. doi: 10.1097/gme.0b013e31821d7ff7.

PMID:
21747303
3.

Relationship between spine osteoarthritis, bone mineral density and bone turn over markers in post menopausal women.

Ichchou L, Allali F, Rostom S, Bennani L, Hmamouchi I, Abourazzak FZ, Khazzani H, El Mansouri L, Abouqal R, Hajjaj-Hassouni N.

BMC Womens Health. 2010 Aug 8;10:25. doi: 10.1186/1472-6874-10-25.

4.

Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.

Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD.

J Bone Miner Res. 1996 Mar;11(3):337-49.

PMID:
8852944
5.

Bone mineral density, arterial stiffness, and coronary atherosclerosis in healthy postmenopausal women.

Seo SK, Cho S, Kim HY, Choi YS, Park KH, Cho DJ, Lee BS.

Menopause. 2009 Sep-Oct;16(5):937-43. doi: 10.1097/gme.0b013e3181a15552.

PMID:
19387416
6.

Chinese bone turnover marker study: reference ranges for C-terminal telopeptide of type I collagen and procollagen I N-terminal peptide by age and gender.

Li M, Li Y, Deng W, Zhang Z, Deng Z, Hu Y, Xia W, Xu L.

PLoS One. 2014 Aug 12;9(8):e103841. doi: 10.1371/journal.pone.0103841. eCollection 2014.

7.

Elevated arterial stiffness in postmenopausal women with osteoporosis.

Sumino H, Ichikawa S, Kasama S, Takahashi T, Kumakura H, Takayama Y, Kanda T, Sakamaki T, Kurabayashi M.

Maturitas. 2006 Oct 20;55(3):212-8. Epub 2006 Apr 18.

PMID:
16621356
8.

Association between basal metabolic function and bone metabolism in postmenopausal women with type 2 diabetes.

Ogata M, Ide R, Takizawa M, Tanaka M, Tetsuo T, Sato A, Iwasaki N, Uchigata Y.

Nutrition. 2015 Nov-Dec;31(11-12):1394-401. doi: 10.1016/j.nut.2015.06.012. Epub 2015 Jul 17.

PMID:
26429661
9.

[ARTERIAL STIFFNESS AND BONE MINERAL DENSITY IN WOMEN WITH CORONARY HEART DISEASE AND CONCOMITANT SEVERE OSTEOPOROSIS].

Tsarenok SY, Gorbunov VV, Panina E S, Aksenova TA, Tereshkov MP, Verkhoturova SV, Gagarkina LS.

Klin Med (Mosk). 2015;93(3):63-8. Russian.

PMID:
26168606
10.

[Study on risk factors of cardiovascular disease and the status of bone mineral density in women with hypoestrogenism].

Zhao F, Guo XT, Cheng Y, Yang ZF, Liu HP.

Zhonghua Fu Chan Ke Za Zhi. 2013 Oct;48(10):734-9. Chinese.

PMID:
24406128
11.

Suppressed bone turnover was associated with increased osteoporotic fracture risks in non-obese postmenopausal Chinese women with type 2 diabetes mellitus.

Jiajue R, Jiang Y, Wang O, Li M, Xing X, Cui L, Yin J, Xu L, Xia W.

Osteoporos Int. 2014 Aug;25(8):1999-2005. doi: 10.1007/s00198-014-2714-5. Epub 2014 Apr 24.

PMID:
24760246
12.

Serum osteopontin levels in relation to bone mineral density and bone turnover markers in postmenopausal women.

Wei QS, Huang L, Tan X, Chen ZQ, Chen SM, Deng WM.

Scand J Clin Lab Invest. 2016;76(1):33-9. doi: 10.3109/00365513.2015.1087045. Epub 2015 Sep 28.

PMID:
26414945
13.

Quantitative ultrasound of bone and markers of bone turnover in Cushing's syndrome.

Cortet B, Cortet C, Blanckaert F, d'Herbomez M, Marchandise X, Wémeau J-L, Decoulx M, Dewailly D.

Osteoporos Int. 2001;12(2):117-23.

PMID:
11303711
14.

The relationship between the metabolic syndrome and its components and bone status in postmenopausal women.

Fodor D, Vesa S, Albu A, Simon S, Craciun A, Muntean L.

Acta Physiol Hung. 2014 Jun;101(2):216-27. doi: 10.1556/APhysiol.101.2014.2.10.

PMID:
24901081
15.

Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis.

Cosman F, Eriksen EF, Recknor C, Miller PD, Guañabens N, Kasperk C, Papanastasiou P, Readie A, Rao H, Gasser JA, Bucci-Rechtweg C, Boonen S.

J Bone Miner Res. 2011 Mar;26(3):503-11. doi: 10.1002/jbmr.238.

16.

Diet, weight, cytokines and bone health in postmenopausal women.

Gunn CA, Weber JL, Kruger MC.

J Nutr Health Aging. 2014 May;18(5):479-86. doi: 10.1007/s12603-014-0002-x.

PMID:
24886734
17.
18.

[The role of biochemical markers of bone turnover in the diagnosis of osteoporosis and predicting fracture risk].

Mohamed Y, Haifa H, Datel O, Fadoua HN, Smeh BH, Mahbouba J, Saoussen Z, Bejia I, Mongi T, Mohamed FN, Naceur B.

Tunis Med. 2014 May;92(5):304-10. French.

19.

The utility of procollagen type 1 N-terminal propeptide for the bone status assessment in postmenopausal women.

Kučukalić-Selimović E, Valjevac A, Hadžović-Džuvo A.

Bosn J Basic Med Sci. 2013 Nov;13(4):259-65.

20.

Relationship between brachial arterial endothelial function and lumbar spine bone mineral density in postmenopausal women.

Sumino H, Ichikawa S, Kasama S, Takahashi T, Sakamoto H, Kumakura H, Takayama Y, Kanda T, Murakami M, Kurabayashi M.

Circ J. 2007 Oct;71(10):1555-9.

Supplemental Content

Support Center